Mirna Therapeutics
AcquiredAustin, United States · Founded 2007 · $76.3M raised
- Headquarters
- Austin, Texas
- Employees
- 11–50
- Founded
- 2007
- Business Model
- B2B
- Website
- mirnarx.com
- Total Funding
- $76.3M
- Last Round
- $41.8M Series DMay 2015
- Rounds
- 4
About
Mirna Therapeutics was a biopharmaceutical company focused on developing microRNA (miRNA)-directed oncology therapies. Founded in 2007 as a spin-off from Asuragen Inc. in Austin, Texas, Mirna was the first company to advance a microRNA-based therapy into clinical trials for cancer treatment. The company completed an IPO on NASDAQ (ticker: MIRN) in October 2015. In 2017, the company merged with Synlogic, Inc., effectively ending its independent operations.
Summary
Mirna Therapeutics is a Biotech company based in Austin, United States, founded in 2007. It has raised $76.3M in total across 4 rounds, most recently a $41.8M Series D round in May 2015.
Funding History
Aug 2017
Sign up to see all 6 rounds
Venture Round through Merger — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mirna-therapeutics"><img src="https://indexed.vc/api/badge/company/mirna-therapeutics" alt="Mirna Therapeutics on Indexed.vc" width="260" height="76" /></a>